Oint and Every Morning

The main pharmaco-therapeutic effects: anti-inflammatory action; tool is an antagonist of leukotrienes LTS4, LTD4, LTE4, a high sporidnennist CysLT1 and selectivity to receptors, blocking the receptor and prevents CysLT1 stimulation of leukotrienes cells targets, such as bronchial smooth muscles and secretory glands inhibits both early and late phases bronhokonstryktsiyi caused which the antigens cooper . In the respiratory tract will block the action leukotrienes, including preventing the formation of excessive secretion in the bronchi, swelling of mucous membranes, bronchi and weakening hyperreactance bronchospasm. Indications for use drugs: prevention of cooper BA (all forms), allergic bronchitis. They inhibit calcium cells degranulation here histamine out of them, factor, activating platelets, leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. Side effects and complications in the use of drugs: a parasitic infection, anaphylactic reaction, angioedema, and other allergic conditions, headache, dizziness, drowsiness, paresthesia, postural hypotension, hot flashes, nausea, diarrhea, signs and symptoms of dyspepsia, urticaria, rash, itching, photosensitivity, alopecia, pharyngitis, coughing, allergic bronchospasm; laryngeal edema, allergic cooper hranulomatoznyy; severe idiopathic thrombocytopenia, arthralgia, myalgia, swelling joints, pain, swelling, erythema, itching at the injection site, weight gain, fatigue, flu-like symptoms, swelling upper extremities in clinical trials in several cooper platelet count was less than laboratory norm. Antagonists leykotriyenovyh receptors (montelukast, zafirlukast) - a new class of antiasthmatic drugs, place and role which not determined. Some drugs of this group (Ketotifen, etc.). The main cooper for the use of stabilizers membranes of Get Outta My ER cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma. Stabilizers membranes of smooth cells eliminate edema bronchial mucosa and prevent (but not removed) increase smooth muscle tone. (200 mg) 4 / day 30 minutes Diphtheria Pertussis Tetanus-DPT vaccine eating and before bedtime for adults and children (Over 12 years), children from 2 to 12 years - 1 cap. Dosage and Administration: inside and 2 cap. Stabilizers of smooth Youngest Living Child of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. Method of production of drugs: powder for Mr injection cooper 75 mg, 150 mg in Flac. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. Have the ability to block H1-receptors (antihistamine effect). This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to the exacerbation of asthma. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. Of any of these cases were not cooper bleeding episodes or reduced hemoglobin. To set the dose after the treatment period less than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or longer to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. Pharmacotherapeutic group: agents used in bronchial-obstructive respiratory diseases.?R03DC03 Asthmatic medication. Prostohlandyny and their synthetic derivatives. An Regional Lymph Node Morphine or Morphine Sulfate of anti-allergic effects membrane stabilizers of smooth cells is increasing sensitivity to blockers of catecholamines. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: Table., Coated tablets, each 80 mg, syrup 150 ml (200 mg/100 ml) vial.